[1]
Pangalila, K.H. et al. 2022. Use of the GnRH Antagonist Elagolix for Endometriosis in Relation to Hypoestrogenic Effect in Women. Jurnal Biologi Tropis. 22, 2 (May 2022), 541–548. DOI:https://doi.org/10.29303/jbt.v22i2.3344.